期刊
MOLECULAR AND CELLULAR ENDOCRINOLOGY
卷 322, 期 1-2, 页码 56-63出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.mce.2010.02.007
关键词
Sodium iodide symporter (NIS); Congenital hypothyroidism; Iodide transport defect; NIS mutations
资金
- Deutsche Forschungsgemeinschaft Bonn, Germany [SFB 824]
- Wilhelm-Sander-Stiftung [2008.037.1]
- NCI [CA91956]
- Minnesota Partnership for Biotechnology and Medical Genomics [08-06]
Molecular cloning of the NIS gene in 1996 allowed examination of the molecular basis of congenital hypothyroidism due to iodide transport defect (ITD) many years after the first case was described by Federman et al. in 1958. Since 1997, when the first NIS mutation causing ITD was identified and characterized, 12 different NIS molecular defects have been described in 31 ITD patients. Interestingly, marked clinical heterogeneity between patients with the same NIS mutation and in patients with different mutations in the NIS gene without a clear genotype-phenotype correlation has been observed. The study of NIS mutations as the molecular basis of ITD has not only yielded extremely valuable structure/function information on NIS, but has also provided an important tool for preclinical diagnosis and genetic counseling of ITD patients. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据